Post date January 13, 2023 Experience Cactus $172.5 million follow-on offering We advised Cactus on the stock offering
Post date January 3, 2023 Experience Tellurian $500 million at-the-market offering The shares are listed on the NYSE
Post date October 26, 2022 Experience ADT $1.2 billion cash tender offer for stock The company’s shares are traded on the NYSE
Post date October 17, 2022 Experience European Biotech Acquisition $200 million combination with Oculis We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Post date September 30, 2022 Experience Solid Biosciences $75 million common stock PIPE offering The financing is taking place concurrently with the company’s acquisition of AavantiBio
Post date June 3, 2022 Experience Tellurian $500 million registered direct offering The convertible senior secured notes are due 2025
Post date December 8, 2021 Experience Virgin Acquisition Corp. II $1.5 billion combination with Grove Collaborative We are advising Virgin Acquisition Corp. II on the transaction
Post date November 10, 2021 Experience Tellurian $50 million senior notes offering The 8.25% investment-grade notes are due 2028
Post date October 8, 2021 Experience Nuvei $425 million U.S. IPO We advised Nuvei on its U.S. IPO and Nasdaq listing of subordinate voting shares
Post date September 27, 2021 Experience Brilliant Earth Group $115 million IPO We advised the underwriters on the IPO and Nasdaq listing